Related Experiment Video
Updated: May 11, 2026

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa
Published on: February 18, 2014
Drug export pathway of multidrug exporter AcrB revealed by DARPin inhibitors
Gaby Sennhauser1, Patrick Amstutz, Christophe Briand
1University of Zurich, Zurich, Switzerland.
Abstract:
The multidrug exporter AcrB is the inner membrane component of the AcrAB-TolC drug efflux system in Escherichia coli and is responsible for the resistance of this organism to a wide range of drugs. Here we describe the crystal structure of the trimeric AcrB in complex with a designed ankyrin-repeat protein (DARPin) inhibitor at 2.5-A resolution. The three subunits of AcrB are locked in different conformations revealing distinct channels in each subunit. There seems to be remote conformational coupling between the channel access, exit, and the putative proton-translocation site, explaining how the proton motive force is used for drug export. Thus our structure suggests a transport pathway not through the central pore but through the identified channels in the individual subunits, which greatly advances our understanding of the multidrug export mechanism.
Insights
The crystal structure of the multidrug exporter AcrB reveals distinct channels within its subunits, suggesting a novel drug export pathway. This finding advances understanding of how Escherichia coli achieves multidrug resistance.
Area of Science:
- Structural Biology
- Microbiology
- Biochemistry
Background:
- AcrB is a key component of the AcrAB-TolC efflux system in Escherichia coli, conferring resistance to numerous drugs.
- Understanding the mechanism of AcrB is crucial for combating antimicrobial resistance.
Purpose of the Study:
- To elucidate the structural basis of the multidrug exporter AcrB's function.
- To investigate the drug transport pathway and proton motive force utilization.
Main Methods:
- X-ray crystallography was used to determine the structure of trimeric AcrB.
- A designed ankyrin-repeat protein (DARPin) inhibitor was used in complex with AcrB.
Main Results:
- The crystal structure of AcrB in complex with a DARPin inhibitor was resolved at 2.5-A resolution.
- The three AcrB subunits were observed in distinct conformations, revealing unique channels within each subunit.
- Evidence suggests remote conformational coupling between channel access, exit, and proton translocation sites.
Conclusions:
- The multidrug export pathway likely involves channels within individual AcrB subunits, not a central pore.
- This structural insight provides a deeper understanding of the AcrB-mediated multidrug efflux mechanism.
- The findings advance knowledge of how proton motive force drives drug export in bacteria.
More Related Videos
Related Concept Videos
ABC Transporters: Exporter
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Export of Misfolded Proteins out of the ER
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

